In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

Researchers released a study suggesting both sugary drinks and diet sodas are associated with a higher risk of consumers ...

Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...

A study by the University of California, Irvine, published in Nature Metabolism, has found that inulin—a natural fiber found ...

Fatty Liver Disease is a common condition, and affects thousands of people all over the world. Apart from medication, and ...

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...

Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s ...

Opting for a diet fizzy drink instead of the sugary version won't protect your liver after all, Britons have been warned. A ...

Drinking diet and sugary beverages may raise the risk of nonalcoholic fatty liver disease by up to 60%, according to new ...

“If you have or are at risk for MASLD, the most important thing you can do is lose weight. Weight loss can help reduce liver ...

Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s fastest-growing diseases. And it’s increasingly occurring in young people ...

Two everyday medications, pemafibrate and telmisartan, could offer a safer, faster route to treating fatty liver disease.